Denali Therapeutics (DNLI)
NASDAQ:DNLI
Holding DNLI?
Track your performance easily

Denali Therapeutics (DNLI) Balance Sheet

606 Followers

Denali Therapeutics Balance Sheet

Denali Therapeutics's total assets for Q2 2024 were $1.50B, an increase of 30.21% from the previous quarter. DNLI total liabilities were $115.48M for the fiscal quarter, a -6.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 1.15B$ 1.46B$ 1.40B$ 1.60B$ 553.23M
Total Liabilities
$ 122.96M$ 417.81M$ 441.87M$ 453.75M$ 158.34M
Total Equity Gross Minority
$ 1.03B$ 1.04B$ 962.29M$ 1.15B$ 394.89M
Total Capitalization
$ 1.08B$ 1.10B$ 962.29M$ 1.15B$ 394.89M
Preferred Stock Equity
-----
Capital Lease Obligations
--$ 64.01M$ 68.86M$ 72.53M
Currency in USD

Denali Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis